How Pseudomonas aeruginosa builds and controls its protective outer layers
Characterizing the regulation of cell envelope biosynthesis in Pseudomonas aeruginosa
Researchers are mapping how the bacteria Pseudomonas aeruginosa builds and balances its outer envelope so future treatments can make infections easier to kill.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11252549 on NIH RePORTER |
What this research studies
If you have a Pseudomonas infection, this work looks inside the bacteria to see how it makes the lipids and sugars that form its protective envelope. The team will track shared chemical building blocks and study the proteins that control when and how each layer is made using lab-grown bacterial strains and biochemical and genetic tests. They will test what happens when those control points are changed to find weak spots in the envelope. Findings could point to new drug targets or ways to boost existing antibiotics.
Who could benefit from this research
Good fit: People with Pseudomonas aeruginosa infections—for example chronic lung infections (including cystic fibrosis), wound infections, or hospital-acquired infections—are the population most likely to benefit from this work.
Not a fit: Patients with infections caused by unrelated microbes or those without bacterial infections are unlikely to receive direct benefit from this specific project.
Why it matters
Potential benefit: Could identify targets or strategies that make Pseudomonas infections easier to treat, especially for antibiotic-resistant cases.
How similar studies have performed: Related work in other gram-negative bacteria has shown envelope components can be effective antibiotic targets, but the regulatory systems in Pseudomonas are less well understood and more novel.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Hummels, Katherine Ruth — University of Georgia
- Study coordinator: Hummels, Katherine Ruth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.